We outline the potential for multitarget therapy incorporating reninangiotensinaldosterone system inhibitors, sodiumglucose co-transporter-2 inhibitors, incretin-based treatments and nsMRAs to improve cardiovascular and kidney outcomes in patients with overweight/obesity and T2DM
Gradual dose increases and symptom tracking can help make side effects easier to manage
HbA1c provides a longitudinal assessment, while self-monitoring of blood glucose offers immediate feedback
In the long term, ALCAR supports brain aging and neuroprotection, offering a holistic boost to both physical performance and mental wellness
10.2147/DDDT.S82030 7 KeremiB.LohinaiZ.KomoraP.DuhajS.BorsiK.JobbaGy-OvariG.et al (2009)
Its essential to be aware of potential side effects, risks, and what may happen if you stop taking them